Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988112311548
Publisher
SAGE Publications
Online
2023-03-20
DOI
10.1177/02698811231154852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
- (2022) Natalie Gukasyan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder
- (2022) Deepak Cyril D’Souza et al. NEUROPSYCHOPHARMACOLOGY
- Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
- (2022) Jacob S. Aday et al. PSYCHOPHARMACOLOGY
- Expectancy in placebo-controlled trials of psychedelics: if so, so what?
- (2022) Matt Butler et al. PSYCHOPHARMACOLOGY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serotonin toxicity of serotonergic psychedelics
- (2021) Benjamin Malcolm et al. PSYCHOPHARMACOLOGY
- Blinding and expectancy confounds in psychedelic randomized controlled trials
- (2021) Suresh D. Muthukumaraswamy et al. Expert Review of Clinical Pharmacology
- Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials
- (2021) Eduardo Ekman Schenberg Expert Review of Clinical Pharmacology
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
- (2020) Gabrielle I Agin-Liebes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial
- (2019) Elias Dakwar et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial
- (2019) Elias Dakwar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
- (2018) Timothy I. Michaels et al. BMC Psychiatry
- Clinical applications of hallucinogens: A review.
- (2016) Albert Garcia-Romeu et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
- (2016) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
- (2009) Janet B.W. Williams et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now